3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
6
Colorectal Neoplasms
3
Osteosarcoma
2
Neoplasms
2
Wilms Tumor
1
Small Bowel Adenocarcinoma
1
Sarcoma, Ewing
1
Sarcoma
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Rectal Neoplasms
1
Rectal Cancer Patients
1
Ovarian Neoplasms
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neuroblastoma
1
Neoplasm Metastasis
1
Metastatic Gastric Adenocarcinoma
1
Metastatic Adenocarcinoma of the Pancreas
1
Hepatoblastoma
1
Fallopian Tube Neoplasms
1
Esophageal Neoplasms
1
Central Nervous System Neoplasms
1
Carcinoma, Ovarian Epithelial
1
Advanced Rectal Cancer
1
Interventions
Temozolomide
10
Radiotherapy
5
Radiation
4
Magnetic Resonance Spectroscopy
4
Ipilimumab
3
pembrolizumab
2
Specimen Handling
2
Photons
2
Nivolumab
2
veliparib
1
sargramostim
1
peposertib
1
montanide ISA 51
1
liposomal doxorubicin
1
cemiplimab
1
balstilimab
1
abexinostat
1
X-Rays
1
Vorinostat
1
Utrogestan
1
Surgical Procedures, Operative
1
Sonication
1
Progestins
1
Progesterone
1
Perfusion Magnetic Resonance Imaging
1
Mycophenolic Acid
1
Lomustine
1
Irinotecan
1
Drug Therapy
1
Contrast Media
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Gliosarcoma
×
irinotecan sucrosofate
×
90 days
×
Clear all
No trials found.